Invion Limited (ASX: IVX)
Health Care · Pharmaceuticals · AU
AU$0.04
-2.56% today · -62.0% 1Y
Invion Limited (ASX: IVX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.90M and employs 8 people.
Over the last twelve months the share price has lost 62.0%, trading between 0.03 and 0.11.
Tweenvest scores Invion Limited across four factors: quality 29/100, value 37/100. Its strongest factor is value.
IVX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.90M
- Revenue (TTM)
- $266.14K
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 0.45
- 52-week high
- AU$0.11
- 52-week low
- AU$0.03
- Avg volume (3M)
- —
- Shares outstanding
- 109.20M
- Employees
- 8
- Next earnings
- —
About Invion Limited
Invion Limited, an Australian clinical-stage life sciences enterprise, is actively engaged in the research and development of photodynamic therapy (PDT) to address various cancer types. Its flagship offering, IVX-PDT, is a photosensitizer agent being developed to combat skin cancers alongside a range of solid tumors, including those affecting the lungs, prostate, ovaries, and mesothelioma. The company has forged a research and development alliance with the Hudson Institute of Medical Research, jointly pursuing R&D initiatives for its Photosoft technology across a broad spectrum of cancer treatments. Moreover, a dedicated research agreement with the Peter MacCallum Cancer Centre facilitates pre-clinical and in-vitro investigations into Invion's IVX-PDT for ano-genital cancers, such as penile and anal cancers. The firm was established in 2000 and is headquartered in Melbourne, Australia.
- ISIN
- AU000000IVX4
- Founded
- 2000
- Listed since
- Feb 14, 2010
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nextleaf Solutions Ltd.CNSX: OILS | $2.98M | CA$0.03 | -16.67% |
| Medicamen Organics LimitedNSEI: MEDIORG | $2.94M | Rs23.35 | -4.89% |
| Nextgen Biomed LtdTASE: NXGN-M | $2.93M | ₪— | — |
| Gujarat Terce Laboratories LimitedBSE: 524314 | $2.91M | Rs36.20 | +2.96% |
| Noveris Health Sciences Inc.CNSX: NVRS | $2.87M | CA$0.07 | -12.50% |
| Eastgate Biotech Corp.OTCPK: ETBI | $2.86M | $0.00 | -46.00% |
| SOHM, Inc.OTCPK: SHMN | $2.81M | $0.00 | +7.78% |
| Clearmind Medicine Inc.NasdaqCM: CMND | $2.77M | $6.58 | 0.00% |
Figures last refreshed Oct 11, 2026.